The Wnt/β-catenin signalling pathway in Haematological Neoplasms

Abstract Leukaemia and lymphoma are common malignancies. The Wnt pathway is a complex network of proteins regulating cell proliferation and differentiation, as well as cancer development, and is divided into the Wnt/β-catenin signalling pathway (the canonical Wnt signalling pathway) and the noncanon...

Full description

Bibliographic Details
Main Authors: Siwei Yu, Ruyue Han, Runliang Gan
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-022-00418-9
_version_ 1798030011928674304
author Siwei Yu
Ruyue Han
Runliang Gan
author_facet Siwei Yu
Ruyue Han
Runliang Gan
author_sort Siwei Yu
collection DOAJ
description Abstract Leukaemia and lymphoma are common malignancies. The Wnt pathway is a complex network of proteins regulating cell proliferation and differentiation, as well as cancer development, and is divided into the Wnt/β-catenin signalling pathway (the canonical Wnt signalling pathway) and the noncanonical Wnt signalling pathway. The Wnt/β-catenin signalling pathway is highly conserved evolutionarily, and activation or inhibition of either of the pathways may lead to cancer development and progression. The aim of this review is to analyse the mechanisms of action of related molecules in the Wnt/β-catenin pathway in haematologic malignancies and their feasibility as therapeutic targets.
first_indexed 2024-04-11T19:34:31Z
format Article
id doaj.art-c894943a9a5c49dfa25e7aa478e78308
institution Directory Open Access Journal
issn 2050-7771
language English
last_indexed 2024-04-11T19:34:31Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Biomarker Research
spelling doaj.art-c894943a9a5c49dfa25e7aa478e783082022-12-22T04:06:55ZengBMCBiomarker Research2050-77712022-10-0110111310.1186/s40364-022-00418-9The Wnt/β-catenin signalling pathway in Haematological NeoplasmsSiwei Yu0Ruyue Han1Runliang Gan2Cancer Research Institute, Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, Hengyang Medical School, University of South ChinaCancer Research Institute, Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, Hengyang Medical School, University of South ChinaCancer Research Institute, Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, Hengyang Medical School, University of South ChinaAbstract Leukaemia and lymphoma are common malignancies. The Wnt pathway is a complex network of proteins regulating cell proliferation and differentiation, as well as cancer development, and is divided into the Wnt/β-catenin signalling pathway (the canonical Wnt signalling pathway) and the noncanonical Wnt signalling pathway. The Wnt/β-catenin signalling pathway is highly conserved evolutionarily, and activation or inhibition of either of the pathways may lead to cancer development and progression. The aim of this review is to analyse the mechanisms of action of related molecules in the Wnt/β-catenin pathway in haematologic malignancies and their feasibility as therapeutic targets.https://doi.org/10.1186/s40364-022-00418-9Wnt/β-catenin signalling pathwayHaematologic neoplasmsLeukaemiaLymphomaMultiple myeloma
spellingShingle Siwei Yu
Ruyue Han
Runliang Gan
The Wnt/β-catenin signalling pathway in Haematological Neoplasms
Biomarker Research
Wnt/β-catenin signalling pathway
Haematologic neoplasms
Leukaemia
Lymphoma
Multiple myeloma
title The Wnt/β-catenin signalling pathway in Haematological Neoplasms
title_full The Wnt/β-catenin signalling pathway in Haematological Neoplasms
title_fullStr The Wnt/β-catenin signalling pathway in Haematological Neoplasms
title_full_unstemmed The Wnt/β-catenin signalling pathway in Haematological Neoplasms
title_short The Wnt/β-catenin signalling pathway in Haematological Neoplasms
title_sort wnt β catenin signalling pathway in haematological neoplasms
topic Wnt/β-catenin signalling pathway
Haematologic neoplasms
Leukaemia
Lymphoma
Multiple myeloma
url https://doi.org/10.1186/s40364-022-00418-9
work_keys_str_mv AT siweiyu thewntbcateninsignallingpathwayinhaematologicalneoplasms
AT ruyuehan thewntbcateninsignallingpathwayinhaematologicalneoplasms
AT runlianggan thewntbcateninsignallingpathwayinhaematologicalneoplasms
AT siweiyu wntbcateninsignallingpathwayinhaematologicalneoplasms
AT ruyuehan wntbcateninsignallingpathwayinhaematologicalneoplasms
AT runlianggan wntbcateninsignallingpathwayinhaematologicalneoplasms